Bryce Point Capital’s Progyny PGNY Stock Holding History

Bryce Point Capital’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,745	Closed	-$898K	–	246
2025 Q1	$898K	Buy	40,745 +20,255	+99%	+$436K	0.68%	51
2024 Q4	$353K	Buy	+20,490	New	+$318K	0.1%	390

Other funds holding PGNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bryce Point Capital's PGNY Position: Q2 2025 in Review

Bryce Point Capital sold out of Progyny (PGNY) in Q2 2025, closing a stake of 40,745 shares — an estimated $898K sold.

Bryce Point Capital first reported a position in PGNY in Q4 2024 and held it in 2 quarters. The position peaked at $898K in Q1 2025. 302 funds tracked by Wall St. Rank hold PGNY as of Q2 2025.

Bryce Point Capital reported no remaining Progyny position as of Q2 2025 after selling out during the quarter.
Bryce Point Capital sold 40,745 Progyny shares in Q2 2025, an estimated $898K.
Bryce Point Capital first reported a position in Progyny in Q4 2024 and held it in 2 quarters.
Bryce Point Capital's Progyny position peaked at $898K in Q1 2025.
302 funds tracked by Wall St. Rank held Progyny as of Q2 2025.

Based on Bryce Point Capital's 13F filing for Q2 2025, filed 5 Aug 2025.